Atlas FDA

TEVADAPTOR Closed Drug Reconstitution and Transfer System, a closed system used to prepare drugs, including cytotoxic dr

FDA device recall Z-1244-2009 · posted 2009-05-06 · Terminated

Recall details

Recalling firm
Migada Inc.
Reason for recall
Syringe adaptor is disintegrating when attached to the end of the syringe.
Action taken
A Field Safety Notice, dated 12/8/2008, was sent to all TEVADAPTOR customers advising them not to use drugs containing N,N-Dimethylacetamide. Teva Medical is presently revising the instruction leaflet supplied with each TEVADAPTOR to include a warning against the use of drugs containing N,N-Dimethylacetamide. Teva Medical will introduce this revised leaflet to current production as soon as practicable. In the meantime, Teva Medical will advise all users of the potential problem by means of the Urgent Field Safety Notice. Customers are to ensure that the safety notice is passed to all those who need to be aware within their organizations. Questions should be directed to their local contacts at B Braun, USA.
Root cause
Component design/selection
Status
Terminated
Product code
LHI
Quantity affected
900,000 units
Distribution
Nationwide Distribution
Date initiated
2008-12-18
Date posted
2009-05-06
Date terminated
2009-07-27
Location
Kiryat Shmona, Israel

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
TEVADAPTOR, CLOSED DRUG RECONSTITUTION AND TRANSFER SYSTEM (K071741)Migada Plant2007-09-24
TEVADAPTOR CLOSED DRUG RECONSTITUTION AND TRANSFER SYSTEM (K051669)Migada Plant2005-09-01